Drug Eye Africa

Morocco recalls two batches of Cardioaspirine 100 mg after temperature excursion

The Agence Marocaine du Médicament et des Produits de Santé (AMMPS) has recalled two batches of Cardioaspirine 100 mg gastro-resistant tablets (acetylsalicylic acid) following a temperature excursion during transport.

Pharmacists and pharmaceutical wholesalers must immediately stop distributing, dispensing and using batches BT1CJP2 and BT1CJP3, quarantine any remaining stock, and return the batches to industrial pharmaceutical establishment Bayer in coordination with the company.

The recall is precautionary. The authority stated that no product quality complaints or pharmacovigilance cases linked to the reason for the recall have been reported to date for these batches.

Source: Agence Marocaine du Médicament et des Produits de Santé (AMMPS), “Rappel de lot de la spécialité pharmaceutique : CARDIOASPIRINE 100 mg – Comprimés gastro-résistants”, 16 September 2026: https://ammps.gov.ma/alertes-et-rappels/rappel-de-lot-de-la-specialite-pharmaceutique-cardioaspirine-100-mg-comprimes-gastro-resistants

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top